For: | Girardin M, Hadengue A, Frossard JL, the Swiss IBD Cohort Study Group. High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients. World J Clin Cases 2018; 6(4): 44-53 [PMID: 29670889 DOI: 10.12998/wjcc.v6.i4.44] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v6/i4/44.htm |
Number | Citing Articles |
1 |
Jessica Hoff, Ling Xiong, Tobias Kammann, Sophie Neugebauer, Julia M. Micheel, Nikolaus Gaßler, Michael Bauer, Adrian T. Press. RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis. Cell Death & Disease 2023; 14(4) doi: 10.1038/s41419-023-05794-0
|
2 |
David C. Montrose, Ryohei Nishiguchi, Srijani Basu, Hannah A. Staab, Xi Kathy Zhou, Hanhan Wang, Lingsong Meng, Melanie Johncilla, Juan R. Cubillos-Ruiz, Diana K. Morales, Martin T. Wells, Kenneth W. Simpson, Shiying Zhang, Belgin Dogan, Chen Jiao, Zhangjun Fei, Akihiko Oka, Jeremy W. Herzog, R. Balfour Sartor, Andrew J. Dannenberg. Dietary Fructose Alters the Composition, Localization, and Metabolism of Gut Microbiota in Association With Worsening Colitis. Cellular and Molecular Gastroenterology and Hepatology 2021; 11(2): 525 doi: 10.1016/j.jcmgh.2020.09.008
|
3 |
Spencer N. Wren, Micah G. Donovan, Ornella I. Selmin, Tom C. Doetschman, Donato F. Romagnolo. A Villin-Driven Fxr Transgene Modulates Enterohepatic Bile Acid Homeostasis and Response to an n-6-Enriched High-Fat Diet. International Journal of Molecular Sciences 2020; 21(21): 7829 doi: 10.3390/ijms21217829
|
4 |
Ralley Prentice, Emma Flanagan, Emily Wright, Lani Prideaux, William Connell, Miles Sparrow, Peter De Cruz, Mark Lust, Winita Hardikar, Rimma Goldberg, Sara Vogrin, Kirsten Palmer, Alyson Ross, Megan Burns, Tessa Greeve, Sally Bell. Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing. Journal of Crohn's and Colitis 2024; 18(7): 1081 doi: 10.1093/ecco-jcc/jjae023
|
5 |
Alireza Beheshti Maal, Mohammad Amin Shahrbaf, Bahareh Sadri, Nikoo Hossein-Khannazer, Mohammad Ali Mansournia, Massoud Vosough. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients. Journal of Crohn's and Colitis 2024; 18(3): 360 doi: 10.1093/ecco-jcc/jjad157
|
6 |
Jocelyn López-Ramirez, Roberto Lazzarini-Lechuga, Monserrat Gerardo-Ramírez, Alejandro Escobedo-Calvario, Lisette Chávez-Rodríguez, Soraya Salas-Silva, Natalia Nuño-Lámbarri, Felipe Massó, Verónica Souza-Arroyo, Roxana U. Miranda-Labra, María Concepción Gutiérrez-Ruiz, Luis E. Gomez-Quiroz, Leticia Bucio-Ortiz. The hepatocyte growth factor induces an anti-inflammatory and repairing response in the cholestasis-induced colon damage. Exploration of Digestive Diseases 2022; : 40 doi: 10.37349/edd.2022.00004
|
7 |
Zahra Barmoudeh, Hossein Sadeghi, Izadpanah Gheitasi, Bahman Khalvati, Navid Omidifar, Mahdokht Azizi, Zahra Moslemi, Jafar Nikbakht, Amir Hossein Doustimotlagh. Fluvoxamine ameliorates oxidative stress and inflammation induced by bile-duct ligation in male rats. Heliyon 2022; 8(12): e12344 doi: 10.1016/j.heliyon.2022.e12344
|